Natera Q3 2022 Earnings Report
Key Takeaways
Natera reported a 33.2% increase in total revenues, reaching $210.6 million in Q3 2022 compared to $158.1 million in Q3 2021. The growth was driven by a 29.8% increase in product revenues, totaling $199.8 million, and a 27.1% increase in test volumes, with approximately 517,500 tests processed.
Total revenues increased by 33.2% to $210.6 million compared to Q3 2021.
Product revenues increased by 29.8% to $199.8 million compared to Q3 2021.
Approximately 517,500 tests were processed, a 27.1% increase compared to Q3 2021.
Net loss was $121.5 million, or ($1.25) per diluted share, compared to a net loss of $151.3 million, or ($1.63) per diluted share, for the same period in 2021.
Natera
Natera
Forward Guidance
Natera anticipates 2022 total revenue of $810 million to $830 million; 2022 gross margin to be approximately 44% to 47% of revenues; selling, general and administrative costs to be approximately $575 million to $590 million; research and development costs to be $320 million to $340 million, and net cash consumption to be approximately $450 million.